CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 375 filers reported holding CRISPR THERAPEUTICS AG in Q1 2023. The put-call ratio across all filers is 1.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,272,873 | -43.9% | 31,313 | -9.8% | 0.08% | -49.7% |
| Q3 2022 | $2,269,000 | +7.5% | 34,727 | 0.0% | 0.16% | +17.9% |
| Q2 2022 | $2,110,000 | +11.6% | 34,727 | +15.3% | 0.14% | +47.4% |
| Q1 2022 | $1,890,000 | +4.2% | 30,113 | +25.8% | 0.10% | -10.4% |
| Q4 2021 | $1,814,000 | +23.4% | 23,933 | +82.3% | 0.11% | +24.7% |
| Q3 2021 | $1,470,000 | -33.5% | 13,129 | -3.9% | 0.08% | -38.8% |
| Q2 2021 | $2,211,000 | – | 13,655 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $32,581,000 | 55.55% |
| NEA Management Company, LLC | 1,590,002 | $103,907,000 | 5.19% |
| ARK Investment Management | 8,237,122 | $538,296,000 | 3.75% |
| Nikko Asset Management Americas, Inc. | 4,262,736 | $277,078,000 | 3.54% |
| CLOUGH CAPITAL PARTNERS L P | 414,767 | $27,105,000 | 2.89% |
| Integral Health Asset Management, LLC | 220,000 | $14,377,000 | 2.79% |
| PLUSTICK MANAGEMENT LLC | 50,000 | $3,268,000 | 2.48% |
| HC Advisors, LLC | 53,944 | $3,525,000 | 2.43% |
| Green Alpha Advisors, LLC | 27,466 | $1,795,000 | 1.52% |
| EFG Asset Management (North America) Corp. | 84,356 | $5,516,000 | 1.28% |